Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMI17NX)

Drug Name

ART621 Drug Info

Indication

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Approved Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Tumor necrosis factor (TNF)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Thalidomide	DM70BU5	Adult T-cell leukemia/lymphoma		Approved	[2]
Nafamostat	DMU1XOD	Pancreatitis	DC31-DC34	Approved	[3]
Pentoxifylline	DMU3DNC	Alcoholic hepatitis	DB94.1	Approved	[4]
Lenalidomide	DM6Q7U4	Adult T-cell leukemia/lymphoma		Approved	[5]
Enbrel	DM7RNP3	Arthritis	FA20	Approved	[6]
Golimumab	DMHZV7X	Psoriatic arthritis	FA21	Approved	[7]
Certolizumab	DM5CL9Z	Rheumatoid arthritis	FA20	Approved	[8]
Etanercept	DMCV109	Arthritis	FA20	Approved	[9]
Adalimumab	DMQMV1B	Crohn disease	DD70	Approved	[10]
Infliximab	DMH7OIA	Crohn disease	DD70	Approved	[11]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	Emerging drugs for psoriasis. Expert Opin Emerg Drugs. 2009 Mar;14(1):145-63.
2	Efficacy of different thalidomide regimens for patients with multiple myeloma and its relationship with TNF-alpha level. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Dec;16(6):1312-5.
3	Clinical pipeline report, company report or official report of AstraZeneca (2009).
4	Targeted therapies in myelodysplastic syndromes: ASH 2003 review. Semin Hematol. 2004 Apr;41(2 Suppl 4):13-20.
5	Thalidomide and thalidomide analogues for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD007351.
6	Oral pentoxifylline inhibits release of tumor necrosis factor-alpha from human peripheral blood monocytes : a potential treatment for aseptic loose... J Bone Joint Surg Am. 2001 Jul;83(7):1057-61.
7	Hughes B: 2009 FDA drug approvals. Nat Rev Drug Discov. 2010 Feb;9(2):89-92.
8	Emerging drugs for rheumatoid arthritis. Expert Opin Emerg Drugs. 2008 Mar;13(1):175-96.
9	The potential of biologics for the treatment of asthma. Nat Rev Drug Discov. 2012 Dec;11(12):958-72.
10	Adalimumab for psoriasis patients who are non-responders to etanercept: open-label prospective evaluation. J Eur Acad Dermatol Venereol. 2009 Dec;23(12):1394-7.
11	Drug insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis. Nat Clin Pract Rheumatol. 2008 Jun;4(6):300-9.